PT Quantum Clovera Investama Tbk

As of June 30, 2026, PT Quantum Clovera Investama Tbk carries a market capitalization of 218.45B, placing it among publicly traded companies globally. Its enterprise value stands at 2.17T, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, PT Quantum Clovera Investama Tbk has 18.20B shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 0.06, and the price-to-book ratio stands at -13,073.02.

These figures are as of June 30, 2026. The EV/Sales ratio of 0.60 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 2.17T versus a market cap of 218.45B, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 15.43B in revenue per employee across its workforce of 235.50, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, PT Quantum Clovera Investama Tbk recorded 4.88B in income tax expense.

As of the close on October 23, 2026, PT Quantum Clovera Investama Tbk's stock has declined approximately 11.76% over the past 52 weeks. The 50-day moving average sits at 15.14, while the 200-day moving average is 16.56.

These figures cover the twelve months ended June 30, 2026.

As of June 30, 2026, PT Quantum Clovera Investama Tbk holds 132.74B in cash and equivalents against 311.13B in total debt, resulting in a net debt position of -132.74B.

These figures cover the twelve months ended June 30, 2026.

PT Quantum Clovera Investama Tbk's most recent stock split took place on June 23, 2016 with a 1:5 split ratio.